Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ballentine

Showing results (341-350 of 357) with videos related to

Pageof 36
Sort By:
Journal of Medicinal Chemistry|June 26, 2007
Acridone-based inhibitors of inosine 5'-monophosphate dehydrogenase: discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2- fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419)Scott H Watterson, Ping Chen, Yufen Zhao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 13, 2015
¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate CancerSteven P Rowe, Kenneth L Gage, Sheila F Faraj, et al.
Trials|November 16, 2021
Working to Increase Stability through Exercise (WISE): screening, recruitment, and baseline characteristicsChristopher N Sciamanna, Noel H Ballentine, Melissa Bopp, et al.
Contemporary Clinical Trials|September 28, 2018
Working to Increase Stability through Exercise (WISE): Study protocol for a pragmatic randomized controlled trial of a coached exercise program to reduce serious fall-related injuriesChristopher Sciamanna, Noel H Ballentine, Melissa Bopp, et al.
Molecular Cancer Therapeutics|November 6, 2009
JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemiaCarl L Manthey, Dana L Johnson, Carl R Illig, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2021
High <sup>3</sup>He/<sup>4</sup>He in central Panama reveals a distal connection to the Galápagos plumeDavid V Bekaert, Esteban Gazel, Stephen Turner, et al.
Archives of Pathology & Laboratory Medicine|August 6, 2014
The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer FoundationMahul B Amin, Daniel W Lin, John L Gore, et al.
Digital Health|June 13, 2025
Answering real-world clinical questions using large language model, retrieval-augmented generation, and agentic systemsYen Sia Low, Michael L Jackson, Rebecca J Hyde, et al.
Science Immunology|November 8, 2024
Macrophage LRRK2 hyperactivity impairs autophagy and induces Paneth cell dysfunctionShengxiang Sun, Miki Hodel, Xiang Wang, et al.
Nature|April 26, 2019
Forearc carbon sink reduces long-term volatile recycling into the mantleP H Barry, J M de Moor, D Giovannelli, et al.
Pageof 36

Showing results (341-350 of 357) with videos related to

Sort By:
Pageof 36
Journal of Medicinal Chemistry|June 26, 2007
Acridone-based inhibitors of inosine 5'-monophosphate dehydrogenase: discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2- fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419)Scott H Watterson, Ping Chen, Yufen Zhao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 13, 2015
¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate CancerSteven P Rowe, Kenneth L Gage, Sheila F Faraj, et al.
Trials|November 16, 2021
Working to Increase Stability through Exercise (WISE): screening, recruitment, and baseline characteristicsChristopher N Sciamanna, Noel H Ballentine, Melissa Bopp, et al.
Contemporary Clinical Trials|September 28, 2018
Working to Increase Stability through Exercise (WISE): Study protocol for a pragmatic randomized controlled trial of a coached exercise program to reduce serious fall-related injuriesChristopher Sciamanna, Noel H Ballentine, Melissa Bopp, et al.
Molecular Cancer Therapeutics|November 6, 2009
JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemiaCarl L Manthey, Dana L Johnson, Carl R Illig, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2021
High <sup>3</sup>He/<sup>4</sup>He in central Panama reveals a distal connection to the Galápagos plumeDavid V Bekaert, Esteban Gazel, Stephen Turner, et al.
Archives of Pathology & Laboratory Medicine|August 6, 2014
The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer FoundationMahul B Amin, Daniel W Lin, John L Gore, et al.
Digital Health|June 13, 2025
Answering real-world clinical questions using large language model, retrieval-augmented generation, and agentic systemsYen Sia Low, Michael L Jackson, Rebecca J Hyde, et al.
Science Immunology|November 8, 2024
Macrophage LRRK2 hyperactivity impairs autophagy and induces Paneth cell dysfunctionShengxiang Sun, Miki Hodel, Xiang Wang, et al.
Nature|April 26, 2019
Forearc carbon sink reduces long-term volatile recycling into the mantleP H Barry, J M de Moor, D Giovannelli, et al.
Pageof 36